Combination therapy with butomelide and rifampicin in experimental tuberculosis in albino mice
Pershin, G.N.; Zykova, T.N.; Kutchak, S.N.
Problemy Tuberkuleza 1: 64-69
1977
ISSN/ISBN: 0032-9533 PMID: 834763 Document Number: 112703
Document emailed within 1 workday
Related Documents
Toyoara, M.; Iwasaki, T. 1971: Anti-tuberculosis activity of rifampicin for experimental tuberculosis of mice Kekkaku: 46(1): 19-22Kurunov, I.N.; Kaledin, V.I.; Popova, N.A.; Panteleeva, A.G. 1992: Effectiveness of a liposomal form of rifampicin in the treatment of experimental tuberculosis in mice Problemy Tuberkuleza 1992(1-2): 13-15
Rossolini, A.; Cellesi, C.; Debolini, A. 1973: Experimental study of liver damage due to rifampicin and rifampicin-isoniazid combination Il Farmaco; Edizione Pratica 28(6): 345-355
Sosnowski, W.; Tomaszkiewicz, L. 1973: Bacteriologic results of treatment with rifampicin and ethambutol administered continuously or intermittently in experimental tuberculosis in white mice Gruzlica i Choroby Pluc; Tuberculosis et Pneumonologia 41(3): 213-224
Ryzhkova, V.V.; Pavlovich, N.V.; Makarovskaia, L.N.; Zurabian, V.A.; Bespalova, I.A.; Goncharov, E.K.; Bugaeva, O.K.; Malsova, N.N. 1996: Increased effectiveness of etiotropic therapy of experimental plague in albino mice at the stage of generalized infection Antibiotiki i Khimioterapiia 41(2): 35-39
Kozulitsyna, T.I.; Kozlova, N.V. 1976: Effectiveness of the drugs of streptomycin group in experimental studies on albino mice infected with Mycobacterium tuberculosis resistant to these drugs Problemy Tuberkuleza 9: 70-74
Moisa, I.; Demetrescu, R. 1970: Comparative studies of the susceptibility of some lines of mice to influenza viruses. I. Experimental study of some strains of type a and A2 in A2G, CBA, C3H (hybrid) and albino mice Studii Si Cercetari de Inframicrobiologie 21(2): 111-117
Kondo, E.; Kanai, K. 1977: Experimental studies on the effective regimens of antituberculous drugs in the treatment of tuberculosis. II. Long-term chemotherapy in mice by daily and intermittent administration with changing drug combination Kekkaku: 52(8): 373-376
Zwolska-Kwiek, Z.; Ceglecka-Tomaszewska, K.; Ziółkowski, J. 1982: Serum rifampicin level in children with tuberculosis and in young mice Pneumonologia Polska 50(11): 571-579
Coban, A.Y.; Bilgin, K.; Uzun, M.; Durupinar, B. 2009: Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates Mikrobiyoloji Bulteni 43(2): 293-297
Mankhatitham, W.; Lueangniyomkul, A.; Manosuthi, W. 2011: Hepatotoxicity in patients co-infected with tuberculosis and HIV-1 while receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy and rifampicin-containing anti-tuberculosis regimen Southeast Asian Journal of Tropical Medicine and Public Health 42(3): 651-658
Sunpath, H.; Winternheimer, P.; Cohen, S.; Tennant, I.; Chelin, N.; Gandhi, R.T.; Murphy, R.A. 2014: Double-dose lopinavir-ritonavir in combination with rifampicin-based anti-tuberculosis treatment in South Africa International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 18(6): 689-693
Uvarova, O.A.; Kozulitsina, T.I.; Korotaev, G.A. 1971: Healing processes in experimental tuberculosis treated with rifampicin and ethambutol Problemy Tuberkuleza 49(12): 56-60
Grasso, E.; Mondino, P.; Spirolazzi, M.P.; Dalmasso, G.; Raineri, G.; Vitiello, C. 1988: Our experience with a combination of rifampicin and minocycline in the therapy of brucellosis Minerva Medica 79(3): 235-240
Westfal, I.; Zengteler, G.; Szymaczek-Meyer, L. 1974: Microscopic changes in liver in experimental tuberculosis in guinea pigs treated with rifampicin Gruzlica i Choroby Pluc; Tuberculosis et Pneumonologia 42(9): 879-885
Panchagnula, R.; Singh, I.; Kaur, K.J.; Kaul, C.L. 1999: Bioequivalence study of rifampicin in fixed-dose combination of rifampicin and isoniazid vs. separate formulations Methods and Findings in Experimental and Clinical Pharmacology 21(9): 625-628
Kurihara, M.; Uchida, J.; Fujioka, A.; Kato, T.; Ohshimo, H.; Abe, M.; Takeda, S.; Fukushima, M. 1997: Effect of combination therapy with UFT plus cisplatin (UFTP) on the survival of mice in the experimental model for wide-spread metastasis in the peritoneal cavity of gastrointestinal cancer using colon 26 PMF-15 cells Anticancer Research 17(3c): 2217-2220
Ryzhko, I.V.; Tsuraeva, R.I.; Pasiukov, V.V.; Samokhodkina, E.D.; Shcherbaniuk, A.I. 1996: Third generation cephalosporins (cefoperazone, cefotaxime, ceftazidime and ceftriaxone) in the prevention and treatment of experimental plague in albino mice Antibiotiki i Khimioterapiia 41(5): 35-38
Samokhodkina, E.D.; Ryzhko, I.V.; Tsuraeva, R.I.; Pasiukov, V.V. 1994: Beta-lactam antibiotics (ampicillin, cefotaxime) in prevention of experimental plague in albino mice, caused by non-fractioned strains of the pathogen Antibiotiki i Khimioterapiia 39(7): 20-23
Ryzhko, I.V.; Shcherbaniuk, A.I.; Moldavan, I.A.; Tsuraeva, R.I.; Anisimov, B.I.; Trishina, A.V. 2007: Efficacy of cefixime and cefepime vs. other cephalosporins in experimental plague of albino mice due to variants FI+ and FI- of the plague microbe Antibiotiki i Khimioterapiia 52(9-10): 24-27